Skip to content
Menu
Home
Health & Tech
FDA & EMA
Oncology
Contact
Pharminent
Search for:
×
Your Name
Your Email
Confirm Your Email
Your Message
News – European Pharmaceutical Review
Shift to automated and sustainable options shaping environmental monitoring market
March 28, 2025
Tariffs could threaten medicine innovation, industry bodies warn
March 27, 2025
FDA approves first-in-class oral antibiotic
March 26, 2025
MSD to advance investigational Lp(a) inhibitor in nearly $2b deal
March 25, 2025
Optimal biosafety cabinet cleaning strategy proposed
March 24, 2025
Innovating intelligent cleanroom control systems
March 21, 2025
Big Molecule Watch
Henlius Receives Orphan-Drug Designation for HLX22 (anti-HER2 mAb) for Gastric Cancer
March 28, 2025
FDA Approves Fresenius’s Denosumab Biosimilars
March 27, 2025
Celltrion Wins Costco Formulary Listing for its Recently Launched Ustekinumab
March 25, 2025
FDA Accepts BLA for Alvotech and Dr. Reddy’s Denosumab Biosimilars
March 20, 2025
Celltrion Launches STEQEYMA® (ustekinumab-stba) in the United States
March 19, 2025
Drug Channels
The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments
March 31, 2025
The New Playbook for Patient Support Programs: Flexibility, Focus, and Forward-Thinking
March 28, 2025
Drug Channels News Roundup, March 2025: PBM Unbundling Update, Stelara Biosimilar Price War, My $0.02 on the Optum Rx News, Follow the Dollar, and #DCLF2025
March 26, 2025
Reflections and Photos from the Inaugural Drug Channels Leadership Forum 2025
March 25, 2025
Informa Connect’s Life Sciences Pricing & Contracting USA
March 24, 2025
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
March 21, 2025
NOW AVAILABLE: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
March 18, 2025
@ 2025 Pharminent. All rights reserved
Design by ThemesDNA.com
Scroll to Top